REFERENCES
- Achanta A.S., Kowalski J. G., Rhodes C. T. Artificial neural networks: Implications for pharmaceutical sciences. Drug Dev. Ind. Pharm. 1995; 21: 119–155
- Costa F. O., Sousa J. J. S., Pais A. A., Formosinho S. J. Comparison of dissolution profiles of ibuprofen pellets. J. Control. Release 2003; 89: 199–212
- Dressman J. B., Reppas C. In vitro-in vivo correlations for lipophilic, poorly water-soluble drugs. B.T. Gattefosse 2000; 93: 91–100
- Ebube N. K., McCall T., Chen Y, Meyer M. C. Relating formulation variables to in vitro dissolution using an artificial neural network. Pharm. Dev. Technol. 1997; 2(3)225–232
- FD A. Guidance for industry: Dissolution testing of immediate release solid oral dosage forms. FDA, Rockville, MD 1997
- Gobburu J. V. S., Shelver W. H. Quantitative structure–pharmacokinetic relations (QSPR) of beta blockers derived using neural networks. J. Pharm. Sci. 1995; 84(7)862–865
- Gobburu J. V. S., Chen E. P. Artificial neural networks as a novel approach to integrated pharmacokinetic–pharmacodynamic analysis. J. Pharm. Sci. 1996; 85(5)505–510
- Gothoskar A. V., Joshi A. M., Joshi N. H. Pulsatile drug delivery systems: A review. Drug Del. Technol. 2004; 4(5)
- Khuri I., Conlon M. Simultaneous optimization of multiple responses represented by polynomial regression functions. Technometrics 1981; 23: 363–375
- Kostwicz E. S., Brauns U., Becker R., Dressman J. B. Forecasting the oral absorption behavior of poorly soluble weak bases using solubility and dissolution studies in biorelevant media. Pharm. Res. 2002; 19(3)345–349
- Li Y., Rauth A. M., Wu X. Y. Prediction of kinetics of doxorubicin release from sulfopropyl dextran ion-exchange microspheres using artificial neural networks. Eur. J. Pharm. Sci. 2005; 24: 401–410
- Matsuo M., Arimori K., Nakamura C., Nakano M. Delayed-release tablets using hydroxyethylcellulose as a gel-forming matrix. Int. J. Pharm. 1996; 138: 225–235
- Moore J. W., Flanner H. H. Mathematical comparison of dissolution profiles. Pharm. Technol. 1996; 20: 64–74
- Murtoniemi E., Yliruusi J., Kinnunen P., Merkku P., Leiviska K. The advantages by the use of neural networks in modeling the fluidized bed granulation process. Int. J. Pharm. 1994; 108: 155–164
- NeuroShell 2 Release 4.0 Manual, Ward Systems Group, Inc., Frederick, MD, USA.
- Nicolaides E., Symillides M., Dressman J. B., Reppas C. Biorelevant dissolution testing to predict the plasma profile of lipophilic drugs after oral administration. Pharm. Res. 2001; 18(3)380–388
- Parojčić, J., Ibrić, S., Djurić, Z., Jovanovic, M., & Corrigan, O. I. (2006). An investigation into the usefulness of generalized regression neural network analysis in the development of level A in vitro–in vivo correlation. Eur. J. Pharm. Sci., doi:10.1016/j.ejps. 2006.11.010.
- Schultz P., Kleinebudde P. A new multiparticulate delayed release system. Part I: Dissolution properties and release mechanism. J. Control. Release 1997; 47: 181–189
- Takahara J., Takayama K., Nagai T. Multi-objective simultaneous optimization technique based on an artificial neural network in sustained release formulations. J. Control. Release 1997; 49(1)11–20
- Takayama K., Fujikawa M., Obata Y., Morishita M. Neural network based optimization of drug formulations. Adv. Drug Deliv. Rev. 2003; 55: 1217–1231